Lamivudine Zidovudine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct Rx. The primary component is Lamivudine; Zidovudine.
Product ID | 61919-061_35e360f7-dbde-5dd9-e054-00144ff88e88 |
NDC | 61919-061 |
Product Type | Human Prescription Drug |
Proprietary Name | Lamivudine Zidovudine |
Generic Name | Lamivudine Zidovudine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2015-01-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202418 |
Labeler Name | Direct Rx |
Substance Name | LAMIVUDINE; ZIDOVUDINE |
Active Ingredient Strength | 150 mg/1; mg/1 |
Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2015-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202418 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-01 |
Ingredient | Strength |
---|---|
LAMIVUDINE | 150 mg/1 |
SPL SET ID: | 77eccfa0-c03c-49a3-bfa7-f31888d77161 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |